Acute Heart Failure.

Slides:

Advertisements

Similar presentations

Perspective on COMMIT/CCS-2 Trial of Metoprolol in STEMI Christopher Cannon, M.D. Brigham and Women’s Hospital Boston, MA.

Advertisements

AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.

Advanced Ventilation Research

The Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic Review Sean P. Collins, MD,

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Emerging Concepts in Heart Failure

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.

Atrial Fibrillation and PCI

Pharmacy Perspectives in Multiple Myeloma: Relapsed and/or Refractory Disease.

The Use of Noninvasive Ventilation in Emergency Department Patients With Acute Cardiogenic Pulmonary Edema: A Systematic Review Sean P. Collins, MD,

Cardiogenic Shock.

The Clinical Enigma of Cardiogenic Shock

NOACs, AF, and PCI: What Do the Latest Data Suggest?

Heart Failure and Hospital Readmissions

Preventing SCD With a WCD: Reviewing the Results of the VEST Trial

A New Era for NOACs:.

Updates on Noninvasive Ventilation in COPD

Anticoagulation Highlights From the American Heart Association Meeting 2017.

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

Select Topics in Cardiovascular Medicine

PCP Perspectives Clinical Considerations in Hyperkalemia

New Perspectives in AF and PCI: Implications for the Practicing Physician.

Treatment of Complicated Intra-abdominal Infections

Resistant Hypertension

Examining CV Effects of Basal Insulin Therapy

New Perspectives in CAD and PAD: Weighing the Latest Evidence

Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.

What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?

Optimizing Patient Outcomes in IBD

Recurrent Angina: New Tools for an Old Problem

The Chemical Differences Between EPA and DHA.

IL-17 Inhibitors in the Management of Psoriatic Disease

Clinical Updates in RA: New Developments and Insights From Washington

WHO Clinical Classification of PH Complex Cases in PH.

Learning Objectives Classification of VTE Goals of VTE Treatment.

A Better Solution For Cancer Patients With VTE?

A Hard Look at Cardiogenic Shock: IABP-SHOCK II Revisited

Remote Patient Management:

LEADER One Year On.

Using Heart Rate as a Biomarker in Clinical Practice.

Updates in Heart Failure:

Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.

WHAT’S NEW WITH THE TREATMENTS FOR HIGH-RISK DYSLIPIDEMIA?

Trials and Tribulations in VTE: How Do Real-World Data Fit In?

When Is Intrathecal Drug Delivery Appropriate?

CAD and HF Often Coexist

Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.

Current Challenges in Managing Hemophilia

The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.

Challenges in LA SCCHN.

Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.

Improving Adherence to Antiplatelet Therapy After an ACS Event

Background. Current Perspectives on the Management of Iron Deficiency in Chronic Heart Failure.

Clinical Challenges and Updates in Managing Seizure Clusters

Assessing the Burden of Hyperkalemia

Lipid Updates From Spring 2019

When Is Intrathecal Drug Delivery Appropriate?

HF-Related Hospitalization and Readmissions

Assessing the Burden of Hyperkalemia

AHF Epidemiology Readmissions Reduction Program.

Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Evaluating the Science of Cardiogenic Shock

In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?

Exploring the Use of Adeno-Associated Virus for Gene Therapy

PCSK9 Inhibitors and Real-World Evidence

Fresh perspectives ON BASAL Insulins in diabetes care

What's New in NOACs in AF?.

Presentation transcript:

Acute Heart Failure

First Point of Care for AHF

AHF Epidemiology

Postdischarge Event Rate

Demographic and Clinical Characteristics of AHF Patients

Perspective Acute MI vs AHF

ED Challenges

Evidence Supporting Early Use of Vasodilators in Patients Who Are Hypertensive

To Diurese, or Not To Diurese?

Early Intervention Might Mitigate Longer-term Outcomes

Benefits of Noninvasive Ventilation

Benefits of Noninvasive Ventilation (cont)

DOSE Trial

Problems With Traditional Approach With Diuresis

Overlap in Approach

Cardiogenic Shock

Can ED Decisions Improve Outcome?

The AHF Epidemic

Current and Emerging Therapies

Summary

Abbreviations

References

References (cont)

References (cont)

References (cont)